| Literature DB >> 32733845 |
Ye Wu1, Rui Huang1, Jin-Mei Jin1, Li-Jun Zhang1, Hong Zhang1, Hong-Zhuan Chen1, Li-Li Chen1, Xin Luan1.
Abstract
Anoplin is an amphipathic, α-helical bioactive peptide from wasp venom. In recent years, pharmaceutical and organic chemists discovered that anoplin and its derivatives showed multiple pharmacological activities in antibacterial, antitumor, antifungal, and antimalarial activities. Owing to the simple and unique structure and diverse biological activities, anoplin has attracted considerable research interests. This review highlights the advances in structural modification, biological activities, and the outlook of anoplin in order to provide a basis for new drug design and delivery.Entities:
Keywords: anoplin; antimicrobial activity; antitumor activity; structural modification; structure–activity relationship
Year: 2020 PMID: 32733845 PMCID: PMC7358703 DOI: 10.3389/fchem.2020.00519
Source DB: PubMed Journal: Front Chem ISSN: 2296-2646 Impact factor: 5.221
Figure 1(A) Schematic representation of anoplin (1). (B) Helical wheel diagram of anoplin showing the polar and nonpolar faces of the helix. All residues are drawn in helical configuration. Gray symbols represent hydrophobic residues. Yellow symbols represent polar, uncharged residues. Green symbols represent basic residues.
Figure 2(A) Point mutation of nonnatural amino acid. (B) Schematic representation of the ATCUN-anoplin bound to a Cu2+ ion. (C) Structure of dimeric peptides. (D) The conjugation of anoplin to divalent and tetravalent dendrimers.
Figure 3Schematic representation of anoplin–chitosan conjugates.
Figure 4(A) d-Amino acid conversion of anoplin to Ano-D4, 7. (B) Antimicrobial peptides conjugated with fatty acids on the side chain of Ano-D4, 7. (C) Different dimerization positions based on Ano-D4, 7. (D) N-terminal fatty acid modified-dimer Ano-D4, 7.
Figure 5(A) All-hydrocarbon stapled peptide strategy. (B) Strategies to induce helix dimer and trimer formation of designed peptides. N and C designations indicate the amino and carboxy termini in the helix models, respectively. (C) Targeted delivery system based on bioactive peptides. (D) Self-assembly of polymer–peptide conjugates in tumor microenvironment.